MetaADEDB 2.0 @ LMMD
selexipag
(QXWZQTURMXZVHJ-UHFFFAOYSA-N)
Structure
SMILES
O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
Type(s)
Approved
ATC code(s)
B01AC27
Molecular Formula:
C26H32N4O4S
Molecular Weight:
496.622
Log P:
5.3697
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
109.87
CAS Number(s):
475086-01-2
Synonym(s)
1.
selexipag
2.
2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide
3.
ACT 293987
4.
ACT-293987
5.
ACT293987
6.
NS-304
7.
Uptravi
External Link(s)
MeSHC523468
PubChem Compound9913767
BindingDB50235383
ChEBI90844
CHEMBLCHEMBL238804
DrugBankDB11362
DrugCentral5077
IUPHAR/BPS Guide to PHARMACOLOGY7552
KEGGdr:D09994
Therapeutic Target DatabaseD0N2SR
ZINC3990451
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 201
Canada Vigilance: 1
Canada Vigilance
US FAERS
2NauseaFAERS: 119
Canada Vigilance: 2
Canada Vigilance
US FAERS
3PneumoniaFAERS: 86US FAERS
4MyalgiaFAERS: 64US FAERS
5PainFAERS: 63US FAERS
6VomitingFAERS: 60US FAERS
7MalaiseFAERS: 57US FAERS
8FatigueFAERS: 56US FAERS
9AstheniaFAERS: 45US FAERS
10DizzinessFAERS: 42US FAERS
11ArthralgiaFAERS: 39US FAERS
12FlushingFAERS: 34US FAERS
13Back PainFAERS: 33US FAERS
14NasopharyngitisFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Pulmonary arterial hypertensionFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
16HypotensionFAERS: 29US FAERS
17Peripheral swellingFAERS: 28US FAERS
18Abdominal discomfortFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
19InfluenzaFAERS: 25US FAERS
20Disease ProgressionFAERS: 23US FAERS
21Musculoskeletal PainFAERS: 21US FAERS
22Product dose omissionFAERS: 21US FAERS
23Weight decreasedFAERS: 21US FAERS
24BronchitisFAERS: 19US FAERS
25Feeling abnormalFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
26SyncopeFAERS: 19US FAERS
27Drug dose omissionFAERS: 16US FAERS
28Pulmonary HypertensionFAERS: 16US FAERS
29Unevaluable eventFAERS: 16US FAERS
30DehydrationFAERS: 14US FAERS
31Blood potassium increasedFAERS: 13US FAERS
32Chest PainFAERS: 13US FAERS
33Neck PainFAERS: 13US FAERS
34PalpitationsFAERS: 13US FAERS
35Adverse eventFAERS: 11US FAERS
36Oxygen consumption increasedFAERS: 11US FAERS
37Urinary tract infectionFAERS: 11US FAERS
38Bone painFAERS: 10US FAERS
39AnxietyFAERS: 9US FAERS
40Atrial FibrillationFAERS: 9US FAERS
41HypoxiaFAERS: 9US FAERS
42SwellingFAERS: 9US FAERS
43TremorFAERS: 9US FAERS
44Abdominal PainFAERS: 8US FAERS
45AlopeciaFAERS: 8US FAERS
46AscitesFAERS: 8US FAERS
47Chest discomfortFAERS: 8US FAERS
48Fluid overloadFAERS: 8US FAERS
49General physical health deteriorationFAERS: 8US FAERS
50Productive CoughFAERS: 8US FAERS
51Right ventricular failureFAERS: 8US FAERS
52Cardiac ArrestFAERS: 7US FAERS
53Disease complicationFAERS: 7US FAERS
54HypersomniaFAERS: 7US FAERS
55Memory impairmentFAERS: 7US FAERS
56PruritusFAERS: 7US FAERS
57Respiratory FailureFAERS: 7US FAERS
58SinusitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
59ConstipationFAERS: 6US FAERS
60DyspepsiaFAERS: 6US FAERS
61Hospice CareFAERS: 6US FAERS
62InfectionFAERS: 6US FAERS
63SepsisFAERS: 6US FAERS
64StressFAERS: 6US FAERS
65Therapy non-responderFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
66TinnitusFAERS: 6US FAERS
67AsthmaFAERS: 5US FAERS
68BedriddenFAERS: 5US FAERS
69Blood glucose abnormalFAERS: 5US FAERS
70Cerebrovascular accidentFAERS: 5US FAERS
71Concomitant disease aggravatedFAERS: 5US FAERS
72FlatulenceFAERS: 5US FAERS
73Incorrect dose administeredFAERS: 5US FAERS
74Intestinal ObstructionFAERS: 5US FAERS
75OverdoseFAERS: 5US FAERS
76PhotophobiaFAERS: 5US FAERS
77SomnolenceFAERS: 5US FAERS
78ThrombosisFAERS: 5US FAERS
79Accidental overdoseFAERS: 4US FAERS
80Blood glucose increasedFAERS: 4US FAERS
81Blood potassium decreasedFAERS: 4US FAERS
82Blood sodium decreasedFAERS: 4US FAERS
83Burning sensationFAERS: 4US FAERS
84Carbon dioxide increasedFAERS: 4US FAERS
85CellulitisFAERS: 4US FAERS
86ChillsFAERS: 4US FAERS
87Drug ineffectiveFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
88EpistaxisFAERS: 4US FAERS
89Facial PainFAERS: 4US FAERS
90Inappropriate schedule of drug administrationFAERS: 4US FAERS
91LethargyFAERS: 4US FAERS
92Limb discomfortFAERS: 4US FAERS
93Loss of personal independence in daily activitiesFAERS: 4US FAERS
94ParacentesisFAERS: 4US FAERS
95Unresponsive to stimuliFAERS: 4US FAERS
96WheezingFAERS: 4US FAERS
97Ammonia increasedFAERS: 3US FAERS
98Ankle FractureFAERS: 3US FAERS
99Cardiac FlutterFAERS: 3US FAERS
100CholecystitisFAERS: 3US FAERS
101Clostridium difficile infectionFAERS: 3US FAERS
102ColitisFAERS: 3US FAERS
103CryingFAERS: 3US FAERS
104Device breakageFAERS: 3US FAERS
105Device related sepsisFAERS: 3US FAERS
106DisorientationFAERS: 3US FAERS
107Drug titration errorFAERS: 3US FAERS
108ErythemaFAERS: 3US FAERS
109HypersensitivityFAERS: 3US FAERS
110Joint stiffnessFAERS: 3US FAERS
111LymphomaFAERS: 3US FAERS
112NephrolithiasisFAERS: 3US FAERS
113Restless Legs SyndromeFAERS: 3US FAERS
114RetchingFAERS: 3US FAERS
115SclerodermaFAERS: 3US FAERS
116Sinus headacheFAERS: 3US FAERS
117Terminal stateFAERS: 3US FAERS
118TransplantFAERS: 3US FAERS
119TrismusFAERS: 3US FAERS
120Urinary IncontinenceFAERS: 3US FAERS
121Vitreous floatersFAERS: 3US FAERS
122AbasiaFAERS: 2US FAERS
123Acute kidney injuryFAERS: 2US FAERS
124Acute respiratory failureFAERS: 2US FAERS
125ArthritisFAERS: 2US FAERS
126Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
127BlindnessFAERS: 2US FAERS
128Blood alkaline phosphatase increasedFAERS: 2US FAERS
129Blood glucose decreasedFAERS: 2US FAERS
130BrachytherapyFAERS: 2US FAERS
131Breast tendernessFAERS: 2US FAERS
132CholelithiasisFAERS: 2US FAERS
133CyanosisFAERS: 2US FAERS
134CystitisFAERS: 2US FAERS
135Dry skinFAERS: 2US FAERS
136DysgeusiaFAERS: 2US FAERS
137Eating disorder symptomFAERS: 2US FAERS
138Feeling jitteryFAERS: 2US FAERS
139Frustration tolerance decreasedFAERS: 2US FAERS
140Head discomfortFAERS: 2US FAERS
141Hepatic EncephalopathyFAERS: 2US FAERS
142HepatitisFAERS: 2US FAERS
143Hip surgeryFAERS: 2US FAERS
144HyperacusisFAERS: 2US FAERS
145Immune thrombocytopenic purpuraFAERS: 2US FAERS
146IncontinenceFAERS: 2US FAERS
147Limb injuryFAERS: 2US FAERS
148Lower respiratory tract infectionFAERS: 2US FAERS
149Medication ErrorFAERS: 2US FAERS
150Mental impairmentFAERS: 2US FAERS
151Mental status changesFAERS: 2US FAERS
152Multiple allergiesFAERS: 2US FAERS
153Myocardial InfarctionFAERS: 2US FAERS
154No adverse eventFAERS: 2US FAERS
155PallorFAERS: 2US FAERS
156Pericardial effusionFAERS: 2US FAERS
157Pulmonary arterial pressure increasedFAERS: 2US FAERS
158Pulmonary function test decreasedFAERS: 2US FAERS
159RestlessnessFAERS: 2US FAERS
160SluggishnessFAERS: 2US FAERS
161SneezingFAERS: 2US FAERS
162Stevens-Johnson SyndromeFAERS: 2US FAERS
163Sudden deathFAERS: 2US FAERS
164Supraventricular tachycardiaFAERS: 2US FAERS
165TachycardiaFAERS: 2US FAERS
166ThirstFAERS: 2US FAERS
167Tooth ExtractionFAERS: 2US FAERS
168Walking aid userFAERS: 2US FAERS
169Wrong technique in product usage processFAERS: 2US FAERS
170cancer surgeryFAERS: 2US FAERS
171Administration site erythemaFAERS: 1US FAERS
172AgitationFAERS: 1US FAERS
173AmputationFAERS: 1US FAERS
174Angina PectorisFAERS: 1US FAERS
175AngioedemaFAERS: 1US FAERS
176Aortic AneurysmFAERS: 1US FAERS
177Arthropod stingFAERS: 1US FAERS
178Atrial FlutterFAERS: 1US FAERS
179Blood count abnormalFAERS: 1US FAERS
180Blood glucose fluctuationFAERS: 1US FAERS
181Blood magnesium decreasedFAERS: 1US FAERS
182Blood pressure fluctuationFAERS: 1US FAERS
183Blood urine presentFAERS: 1US FAERS
184Bone contusionFAERS: 1US FAERS
185Brain AbscessFAERS: 1US FAERS
186Brain natriuretic peptide increasedFAERS: 1US FAERS
187Cardiac discomfortFAERS: 1US FAERS
188Carotid artery occlusionFAERS: 1US FAERS
189Catheter site thrombosisFAERS: 1US FAERS
190Cerebral InfarctionFAERS: 1US FAERS
191Cerebral hypoperfusionFAERS: 1US FAERS
192ChemotherapyFAERS: 1US FAERS
193ChromaturiaFAERS: 1US FAERS
194Completed SuicideFAERS: 1US FAERS
195Cyst aspirationFAERS: 1US FAERS
196DeliriumFAERS: 1US FAERS
197DementiaFAERS: 1US FAERS
198Dental cariesFAERS: 1US FAERS
199Depressed moodFAERS: 1US FAERS
200Dialysis device insertionFAERS: 1US FAERS
201Drug administration errorFAERS: 1US FAERS
202Drug dose titration not performedFAERS: 1US FAERS
203DysphoniaFAERS: 1US FAERS
204DysuriaFAERS: 1US FAERS
205Ear congestionFAERS: 1US FAERS
206Ear discomfortFAERS: 1US FAERS
207Elective procedureFAERS: 1US FAERS
208Emergency CareFAERS: 1US FAERS
209EndarterectomyFAERS: 1US FAERS
210Extra dose administeredFAERS: 1US FAERS
211Eye inflammationFAERS: 1US FAERS
212Eye painFAERS: 1US FAERS
213Eyelid painFAERS: 1US FAERS
214Facial paralysisFAERS: 1US FAERS
215Feeding tube userFAERS: 1US FAERS
216Foaming at mouthFAERS: 1US FAERS
217Gait inabilityFAERS: 1US FAERS
218GastroenteritisFAERS: 1US FAERS
219Gastrointestinal PainFAERS: 1US FAERS
220Gastrointestinal perforationFAERS: 1US FAERS
221GastrostomyFAERS: 1US FAERS
222HemiplegiaFAERS: 1US FAERS
223Hepatitis CFAERS: 1US FAERS
224HerniaFAERS: 1US FAERS
225HyperthyroidismFAERS: 1US FAERS
226HypokinesiaFAERS: 1US FAERS
227Impaired gastric emptyingFAERS: 1US FAERS
228Inappropriate schedule of product administrationFAERS: 1US FAERS
229IncoherentFAERS: 1US FAERS
230Intentional dose omissionFAERS: 1US FAERS
231Intentional product use issueFAERS: 1US FAERS
232Intercepted product prescribing errorFAERS: 1US FAERS
233Joint swellingFAERS: 1US FAERS
234Labile blood pressureFAERS: 1US FAERS
235LaryngitisFAERS: 1US FAERS
236LazinessFAERS: 1US FAERS
237Limb operationFAERS: 1US FAERS
238Lip swellingFAERS: 1US FAERS
239MastitisFAERS: 1US FAERS
240Medical device removalFAERS: 1US FAERS
241MonoplegiaFAERS: 1US FAERS
242Musculoskeletal chest painFAERS: 1US FAERS
243Neck DissectionFAERS: 1US FAERS
244NeuralgiaFAERS: 1US FAERS
245Oropharyngeal painFAERS: 1US FAERS
246Orthostatic hypertensionFAERS: 1US FAERS
247Oxygen supplementationFAERS: 1US FAERS
248Pain of skinFAERS: 1US FAERS
249Pancreatic carcinomaFAERS: 1US FAERS
250ParesisFAERS: 1US FAERS
251PneumothoraxFAERS: 1US FAERS
252Poor peripheral circulationFAERS: 1US FAERS
253Post procedural complicationFAERS: 1US FAERS
254Pre-existing condition improvedFAERS: 1US FAERS
255PresyncopeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
256Product administration errorFAERS: 1US FAERS
257Product prescribing errorFAERS: 1US FAERS
258Product prescribing issueFAERS: 1US FAERS
259Product supply issueFAERS: 1US FAERS
260Product used for unknown indicationFAERS: 1US FAERS
261Pulmonary EmbolismFAERS: 1US FAERS
262Pulmonary FibrosisFAERS: 1US FAERS
263Pulmonary congestionFAERS: 1US FAERS
264Pulmonary endarterectomyFAERS: 1US FAERS
265Pulmonary painFAERS: 1US FAERS
266Quality of life decreasedFAERS: 1US FAERS
267Rectal ProlapseFAERS: 1US FAERS
268Rehabilitation therapyFAERS: 1US FAERS
269Respiratory distressFAERS: 1US FAERS
270Respiratory tract congestionFAERS: 1US FAERS
271SarcoidosisFAERS: 1US FAERS
272Sensitive skinFAERS: 1US FAERS
273Shunt malfunctionFAERS: 1US FAERS
274SplenomegalyFAERS: 1US FAERS
275Squamous cell carcinomaFAERS: 1US FAERS
276Temperature intoleranceFAERS: 1US FAERS
277TensionFAERS: 1US FAERS
278Therapy cessationFAERS: 1US FAERS
279Therapy changeFAERS: 1US FAERS
280ThrombocytopeniaFAERS: 1US FAERS
281TonsillectomyFAERS: 1US FAERS
282Tooth InfectionFAERS: 1US FAERS
283Transplant evaluationFAERS: 1US FAERS
284Troponin increasedFAERS: 1US FAERS
285UlcerFAERS: 1US FAERS
286Urinary RetentionFAERS: 1US FAERS
287UrticariaFAERS: 1US FAERS
288Vaginal DischargeFAERS: 1US FAERS
289Vascular device infectionFAERS: 1US FAERS
290Vascular graft complicationFAERS: 1US FAERS
291Vascular insufficiencyFAERS: 1US FAERS
292Venoocclusive diseaseFAERS: 1US FAERS
293VertigoFAERS: 1US FAERS
294Volvulus repairFAERS: 1US FAERS
295Vulvovaginal pruritusFAERS: 1US FAERS
296Walking distance test abnormalFAERS: 1US FAERS
297jaundiceFAERS: 1US FAERS
298Pulmonary vascular resistance abnormalityCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.